Company Filing History:
Years Active: 2023
Title: **Constanze A Jakwerth: Innovator in Allergen-Specific Immunotherapy**
Introduction
Constanze A Jakwerth, based in Munich, Germany, is a notable inventor recognized for her contributions to the field of allergen-specific immunotherapy. With a focus on enhancing therapeutic outcomes for patients suffering from allergic diseases, her work exemplifies the intersection of innovation and healthcare.
Latest Patents
Jakwerth holds a significant patent titled "Ratio of immune cells as prognostic indicator of therapeutic success in allergen-specific immunotherapy." This invention involves a method that utilizes a specific ratio of immune cells to predict the success of allergen-specific immunotherapy (AIT) in patients predisposed to or suffering from allergic diseases. Additionally, her patent encompasses a kit designed to assist healthcare providers in evaluating the potential effectiveness of AIT for individual patients.
Career Highlights
Constanze A Jakwerth is affiliated with Klinikum Rechts der Isar der Technischen Universität München, a leading research institution where she applies her expertise in immunology and therapeutic methodologies. Her groundbreaking work in this area has not only advanced scientific knowledge but also has the potential to improve treatment protocols for allergic diseases.
Collaborations
Throughout her career, Jakwerth has collaborated with esteemed colleagues including Carsten Schmidt-Weber and Adam M Chaker, who share a commitment to advancing research in immunotherapy. These collaborations have likely enhanced the innovative processes, leading to the development of impactful solutions for allergy sufferers.
Conclusion
Constanze A Jakwerth is a prominent figure in the field of immunotherapy, with her patent serving as a testament to her innovative spirit and dedication to improving patient outcomes. Her contributions reflect the essential role of inventors in shaping the future of healthcare through science and technology.